NCT00388401View on ClinicalTrials.gov

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

PHASE3CompletedINTERVENTIONAL

Enrollment

510

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

June 30, 2003

Study Completion Date

June 30, 2003

Conditions

Ileus

Interventions

DRUG

Alvimopan

Trial Locations (1)

19341

Adolor Corporation, Exton

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY